BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26446941)

  • 1. A Composite Gene Expression Signature Optimizes Prediction of Colorectal Cancer Metastasis and Outcome.
    Schell MJ; Yang M; Missiaglia E; Delorenzi M; Soneson C; Yue B; Nebozhyn MV; Loboda A; Bloom G; Yeatman TJ
    Clin Cancer Res; 2016 Feb; 22(3):734-45. PubMed ID: 26446941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomic expression profiling identifies ITGBL1, an epithelial to mesenchymal transition (EMT)-associated gene, is a promising recurrence prediction biomarker in colorectal cancer.
    Matsuyama T; Ishikawa T; Takahashi N; Yamada Y; Yasuno M; Kawano T; Uetake H; Goel A
    Mol Cancer; 2019 Feb; 18(1):19. PubMed ID: 30717807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superior breast cancer metastasis risk stratification using an epithelial-mesenchymal-amoeboid transition gene signature.
    Emad A; Ray T; Jensen TW; Parat M; Natrajan R; Sinha S; Ray PS
    Breast Cancer Res; 2020 Jul; 22(1):74. PubMed ID: 32641077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced epithelial-mesenchymal transition signatures are linked with adverse tumor microenvironment, angiogenesis and worse survival in gastric cancer.
    Oshi M; Roy AM; Yan L; Kinoshita S; Tamura Y; Kosaka T; Akiyama H; Kunisaki C; Takabe K; Endo I
    Cancer Gene Ther; 2024 May; 31(5):746-754. PubMed ID: 38532115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal Signals Dominate Gene Expression Signature Scores That Aim to Describe Cancer Cell-intrinsic Stemness or Mesenchymality Characteristics.
    Kreis J; Aybey B; Geist F; Brors B; Staub E
    Cancer Res Commun; 2024 Feb; 4(2):516-529. PubMed ID: 38349551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival Outcomes in Cancer Patients Predicted by a Partial EMT Gene Expression Scoring Metric.
    George JT; Jolly MK; Xu S; Somarelli JA; Levine H
    Cancer Res; 2017 Nov; 77(22):6415-6428. PubMed ID: 28947416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constructing a personalized prognostic risk model for colorectal cancer using machine learning and multi-omics approach based on epithelial-mesenchymal transition-related genes.
    Zhang S; Fan W; He D
    J Gene Med; 2024 Jan; 26(1):e3660. PubMed ID: 38282145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the mystery of colon cancer from the perspective of molecular subtypes and treatment.
    Lu W; Wang Q; Liu L; Luo W
    Sci Rep; 2024 May; 14(1):10883. PubMed ID: 38740818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-Analysis of EMT Datasets Reveals Different Types of EMT.
    Liang L; Sun H; Zhang W; Zhang M; Yang X; Kuang R; Zheng H
    PLoS One; 2016; 11(6):e0156839. PubMed ID: 27258544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The consensus molecular subtypes of colorectal cancer.
    Guinney J; Dienstmann R; Wang X; de Reyniès A; Schlicker A; Soneson C; Marisa L; Roepman P; Nyamundanda G; Angelino P; Bot BM; Morris JS; Simon IM; Gerster S; Fessler E; De Sousa E Melo F; Missiaglia E; Ramay H; Barras D; Homicsko K; Maru D; Manyam GC; Broom B; Boige V; Perez-Villamil B; Laderas T; Salazar R; Gray JW; Hanahan D; Tabernero J; Bernards R; Friend SH; Laurent-Puig P; Medema JP; Sadanandam A; Wessels L; Delorenzi M; Kopetz S; Vermeulen L; Tejpar S
    Nat Med; 2015 Nov; 21(11):1350-6. PubMed ID: 26457759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and Predictive Biomarkers in Colorectal Cancer. From the Preclinical Setting to Clinical Practice.
    Maurel J; Postigo A
    Curr Cancer Drug Targets; 2015; 15(8):703-15. PubMed ID: 26452385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer.
    Okugawa Y; Toiyama Y; Toden S; Mitoma H; Nagasaka T; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
    Gut; 2017 Jan; 66(1):107-117. PubMed ID: 26475630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation Spectra of Common Cancer-Associated Genes in Different Phenotypes of Colorectal Carcinoma Without Distant Metastasis.
    Chang SC; Lin PC; Lin JK; Lin CH; Yang SH; Liang WY; Chen WS; Jiang JK
    Ann Surg Oncol; 2016 Mar; 23(3):849-55. PubMed ID: 26471487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing Anti-EGFR Therapy in Colorectal Cancer.
    Salazar R; Ciardiello F
    Clin Cancer Res; 2015 Dec; 21(24):5415-6. PubMed ID: 26463710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Expression of PDLIM2 Predicts a Poor Prognosis in Prostate Cancer and Is Correlated with Epithelial-Mesenchymal Transition and Immune Cell Infiltration.
    Piao S; Zheng L; Zheng H; Zhou M; Feng Q; Zhou S; Ke M; Yang H; Wang X
    J Immunol Res; 2022; 2022():2922832. PubMed ID: 35707002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Three-Genes Signature Predicting Colorectal Cancer Relapse Reveals LEMD1 Promoting CRC Cells Migration by RhoA/ROCK1 Signaling Pathway.
    Zhang H; Xu C; Jiang F; Feng J
    Front Oncol; 2022; 12():823696. PubMed ID: 35619906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLUS: Predicting cancer metastasis potential based on positive and unlabeled learning.
    Zhou J; Lu X; Chang W; Wan C; Lu X; Zhang C; Cao S
    PLoS Comput Biol; 2022 Mar; 18(3):e1009956. PubMed ID: 35349572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ras Pathway Activation and MEKi Resistance Scores Predict the Efficiency of MEKi and SRCi Combination to Induce Apoptosis in Colorectal Cancer.
    Davis TB; Gupta S; Yang M; Pflieger L; Rajan M; Wang H; Thota R; Yeatman TJ; Pledger WJ
    Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of lncRNA MIR100HG with hnRNPA2B1 facilitates m
    Liu H; Li D; Sun L; Qin H; Fan A; Meng L; Graves-Deal R; Glass SE; Franklin JL; Liu Q; Wang J; Yeatman TJ; Guo H; Zong H; Jin S; Chen Z; Deng T; Fang Y; Li C; Karijolich J; Patton JG; Wang X; Nie Y; Fan D; Coffey RJ; Zhao X; Lu Y
    Mol Cancer; 2022 Mar; 21(1):74. PubMed ID: 35279145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy.
    Yang M; Davis TB; Pflieger L; Nebozhyn MV; Loboda A; Wang H; Schell MJ; Thota R; Pledger WJ; Yeatman TJ
    BMC Cancer; 2022 Mar; 22(1):256. PubMed ID: 35272617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.